Sign Up to like & get
recommendations!
1
Published in 2021 at "Mayo Clinic proceedings"
DOI: 10.1016/j.mayocp.2020.11.028
Abstract: OBJECTIVE To describe the clinical and pathological phenotype of membranous nephropathy (MN) associated with M-type-phospholipase-A2-receptor (PLA2R), thrombospondin-type-1-domain-containing-7A (THSD7A), semaphorin 3B (SEMA3B), neural-epidermal-growth-factor-like-1-protein (NELL-1), protocadherin 7 (PCDH7), exostosin 1/exostosin 2 (EXT1/EXT2) and neural cell adhesion molecule…
read more here.
Keywords:
disease;
target;
membranous nephropathy;
target antigen ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2024 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2024-009485
Abstract: Background Infusion of T cells modified with a chimeric antigen receptor (CAR) targeting CD19 has achieved exceptional responses in patients with non-Hodgkin’s lymphoma (NHL), which led to the approval of CAR targeting CD19 (CART19) (Axi-cel…
read more here.
Keywords:
treatment;
loss;
target antigen;
car ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of the American Society of Nephrology : JASN"
DOI: 10.1681/asn.2020101395
Abstract: BACKGROUND Identification of target antigens PLA2R, THSD7A, NELL1, or Semaphorin-3B can explain the majority of cases of primary membranous nephropathy (MN). However, target antigens remain unidentified in 15%-20% of patients. METHODS A multipronged approach, using…
read more here.
Keywords:
serine protease;
target;
htra1;
protease htra1 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Biosensors"
DOI: 10.3390/bios15110759
Abstract: The interaction of therapeutic antibodies with Fc receptors is an important property that is actively modified to improve pharmacokinetic profiles and optimize antibody-dependent mechanisms of action. Various modifications of the Fc and hinge regions of…
read more here.
Keywords:
target antigen;
binding target;
antibodies receptors;
interaction ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15061845
Abstract: Simple Summary Antibody-Drug Conjugates (ADCs) provide effective anti-cancer treatments. ADC development requires the identification of appropriate tumour-associated antigens that can be targeted by the ADC to effectively kill cancer cells while minimising damage to healthy…
read more here.
Keywords:
clinically approved;
drug conjugates;
conjugates adcs;
target antigen ... See more keywords